EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and Optimization of an HPMC/TPGS-Based Apixaban Amorphous Solid Dispersion for Enhanced Supersaturation and Oral Absorption

Jeong-Gyun Lee, Kyeong-Soo Kim

Molecules · 16.11.2026 · 31 (22) · 4133

DOI: 10.3390/molecules31224133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 16.11.2026. Verfasst von Jeong-Gyun Lee und 1 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An apixaban (APX) amorphous solid dispersion (ASD) containing hydroxypropyl methylcellulose (HPMC) and D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) was prepared by spray drying to improve solubility and oral exposure. Screening identified HPMC for supersaturation maintenance and TPGS for apparent solubilization. A central composite design optimized their ratios using five responses: supersaturation solubility, 30-min kinetic solubility, kinetic solubility area under the curve (AUC), particle size, and polydispersity index (PDI). The optimized APX/HPMC/TPGS ratio was 1:3.93:0.85 (w/w/w), with a composite desirability of 0.8491 (on a scale from 0 to 1). Compared with crystalline APX, the optimized ASD increased supersaturation solubility, 30-min kinetic solubility, and kinetic solubility AUC 4.04-, 5.47-, and 8.10-fold, respectively. The dispersed formulation exhibited a particle size of 203.4 ± 17.3 nm and PDI of 0.246 ± 0.018. PXRD and DSC supported predominantly amorphous APX, while electron microscopy and DLS supported nanosized colloidal particle formation. The optimized ASD also maintained higher kinetic solubility in fasted-state simulated intestinal fluid than crystalline and amorphous APX. In rats, Cmax, AUC0–24, and AUC0–inf increased by 2.46-, 3.04-, and 2.80-fold, respectively, versus crystalline APX.

Zitieren

APA

Lee, J., & Kim, K. (2026). Development and Optimization of an HPMC/TPGS-Based Apixaban Amorphous Solid Dispersion for Enhanced Supersaturation and Oral Absorption. Molecules, 31(22), 4133. https://doi.org/10.3390/molecules31224133

Vancouver

Lee J, Kim K. Development and Optimization of an HPMC/TPGS-Based Apixaban Amorphous Solid Dispersion for Enhanced Supersaturation and Oral Absorption. Molecules. 2026;31(22):4133. doi:10.3390/molecules31224133

BibTeX
@article{Lee2026,
  author = {Lee, Jeong-Gyun and Kim, Kyeong-Soo},
  title = {Development and Optimization of an HPMC/TPGS-Based Apixaban Amorphous Solid Dispersion for Enhanced Supersaturation and Oral Absorption},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {22},
  pages = {4133},
  doi = {10.3390/molecules31224133}
}
Kostenlos starten →